Immutep Ltd
ASX:IMM

Watchlist Manager
Immutep Ltd Logo
Immutep Ltd
ASX:IMM
Watchlist
Price: 0.34 AUD
Market Cap: 494.6m AUD
Have any thoughts about
Immutep Ltd?
Write Note

Relative Value

The Relative Value of one IMM stock under the Base Case scenario is 0.73 AUD. Compared to the current market price of 0.34 AUD, Immutep Ltd is Undervalued by 53%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IMM Relative Value
Base Case
0.73 AUD
Undervaluation 53%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
6
vs Industry
4
Median 3Y
1 364.8
Median 5Y
1 026.4
Industry
7.6
Forward
160.4
vs History
vs Industry
Median 3Y
-10
Median 5Y
-9.4
Industry
22.1
Forward
-7.3
vs History
vs Industry
Median 3Y
-11.4
Median 5Y
-11.4
Industry
21.9
vs History
vs Industry
Median 3Y
-11.4
Median 5Y
-11.3
Industry
23.4
vs History
92
vs Industry
31
Median 3Y
3
Median 5Y
3.2
Industry
2.5
vs History
6
vs Industry
4
Median 3Y
1 095.6
Median 5Y
737.6
Industry
7.5
Forward
102.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.3
vs History
vs Industry
Median 3Y
-5.9
Median 5Y
-6.2
Industry
4.2
Forward
-5.1
vs History
vs Industry
Median 3Y
-5.9
Median 5Y
-6.2
Industry
4
Forward
-4.5
vs History
vs Industry
Median 3Y
-7.8
Median 5Y
-8.4
Industry
5.9
vs History
vs Industry
Median 3Y
-7.7
Median 5Y
-8.4
Industry
3.9
vs History
47
vs Industry
16
Median 3Y
16.9
Median 5Y
15.6
Industry
4.5

Multiples Across Competitors

IMM Competitors Multiples
Immutep Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Immutep Ltd
ASX:IMM
498.5m AUD 4 167.1 -11.7 -6.3 -6.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
309B USD 5.6 60.8 15.1 23.3
US
Amgen Inc
NASDAQ:AMGN
141B USD 4.3 33.3 16 30.3
US
Gilead Sciences Inc
NASDAQ:GILD
116B USD 4.1 920.3 10.2 10.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.5B USD 9.7 -215.8 21.3 22.3
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 5.7 16.8 15.4 17.1
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
36B EUR 19.3 -135.6 -109.5 -79.8
P/S Multiple
Revenue Growth P/S to Growth
AU
Immutep Ltd
ASX:IMM
Average P/S: 3 457 618.8
4 167.1
35 588%
0.1
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.3
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.7
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
AU
Immutep Ltd
ASX:IMM
Average P/E: 212.6
Negative Multiple: -11.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
60.8
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.3
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
920.3
77%
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -215.8
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Immutep Ltd
ASX:IMM
Average EV/EBITDA: 16.3
Negative Multiple: -6.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.3
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.5 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Immutep Ltd
ASX:IMM
Average EV/EBIT: 21.3
Negative Multiple: -6.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.3
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.3
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.3
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.8 N/A N/A

See Also

Discover More
Back to Top